Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Helen Louise Collins currently holds 136,268 shares of FIVE PRIME THERAPEUTICS INC (FPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Helen Louise Collins has been a net seller of FPRX stock. They have purchased $0 and sold $3.2M worth of shares.
Helen Louise Collins's most recent insider trade was on Mar 25, 2026, when they sold 40,000 shares at $0.00 per share.
Helen Louise Collins serves as Executive at FIVE PRIME THERAPEUTICS INC (FPRX). They have executed 49 insider transactions totaling $3.2M over their tenure at the company.
Helen Louise Collins holds the position of Executive at FIVE PRIME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Helen Louise Collins has shown a selling trading pattern, with $0 in total purchases and $3.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Helen Louise Collins was on Apr 16, 2021, when they sold $5.2M worth of FPRX shares. This transaction involved 135,547 shares at $38.00 per share.
Helen Louise Collins currently owns 136,268 shares of FIVE PRIME THERAPEUTICS INC (FPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Helen Louise Collins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Helen Louise Collins has 49 Form 4 filings on record as an insider at FIVE PRIME THERAPEUTICS INC.
Set alerts for Helen Louise Collins and 40,000+ other insiders.